Literature DB >> 29953629

Lung histopathology of non-infectious pulmonary complications after allogeneic haematopoietic stem cell transplantation.

Veronique Meignin1, Francoise Thivolet-Bejui2, Marianne Kambouchner3, Claire Hussenet4, Louise Bondeelle4, Andrew Mitchell5, Karine Chagnon6, Hugues Begueret7, Valerie Segers8, Vincent Cottin9,10, Abdellatif Tazi4, Sylvie Chevret11,12, Claire Danel13,14, Anne Bergeron4,12.   

Abstract

AIMS: Non-infectious pulmonary complications (NIPCs) occur frequently following allogeneic haematopoietic stem cell transplantation (HSCT). As there is no consensus on the description of the related pulmonary pathological lesions, pathologist reports and clinical conclusions are largely inconsistent in routine practice. The aim of our study was to provide an accurate overview of post-allogeneic HSCT NIPCs from a large number of lung biopsies. METHODS AND
RESULTS: We reviewed 61 lung biopsies in patients with an NIPC, including 51 surgical lung biopsies, four post-mortem biopsies and six lung explants. We found both bronchiolar (n = 59) and alveolar/interstitial pathologies (n = 27). We describe two types of bronchiolar lesions: bronchiolectasies (n = 37) and fibrous and cellular lesions with luminal narrowing (n = 43). We found a wide spectrum of airway/interstitial pathologies that were labelled using the terminology of the 2013 American Thoracic Society and European Respiratory Society (ATS/ERS) classification of idiopathic interstitial pneumonias (IIPs), including the following: organising pneumonia (OP, n = 8), non-specific interstitial pneumonia (NSIP, n = 9), diffuse alveolar damage (DAD, n = 6), lymphoid interstitial pneumonia (LIP, n = 1) and pleuroparenchymal fibroelastosis (PPFE, n = 2), as well as one instance of associated PPFE and NSIP.
CONCLUSIONS: Interstitial pathology was associated with bronchiolar lesions in 41% of the cases reviewed (n = 25). Lung airway and interstitial inflammation was still present in lung explants from patients who underwent lung transplantation for post-allogeneic HSCT end-stage respiratory insufficiency. Herein, we describe a wide spectrum of pathological lung lesions encountered in post-allogeneic HSCT NIPCs.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990BOSzzm321990; Allogeneic haematopoietic stem cell transplantation; bronchiolitis obliterans; constrictive bronchiolitis; interstitial pneumonia; lung; obliterative bronchiolitis

Mesh:

Year:  2018        PMID: 29953629     DOI: 10.1111/his.13697

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  Fibrotic Cystic Lung Disease Post Hematopoietic Stem Cell Transplant: Who is the Culprit?

Authors:  Walid Alam; Rayan Mohamad; Maysoun Koubaissi; Salwa A Koubaissi
Journal:  Clin Med Insights Case Rep       Date:  2022-05-13

Review 2.  Airway disease in hematologic malignancies.

Authors:  Ricardo J José; Burton F Dickey; Ajay Sheshadri
Journal:  Expert Rev Respir Med       Date:  2022-02-21       Impact factor: 4.300

3.  Beyond Bronchiolitis Obliterans: In-Depth Histopathologic Characterization of Bronchiolitis Obliterans Syndrome after Lung Transplantation.

Authors:  Arno Vanstapel; Stijn E Verleden; Eric K Verbeken; Peter Braubach; Tinne Goos; Laurens De Sadeleer; Janne Kaes; Bart M Vanaudenaerde; Danny Jonigk; Maximilian Ackermann; Laurens J Ceulemans; Dirk E Van Raemdonck; Arne P Neyrinck; Robin Vos; Geert M Verleden; Birgit Weynand
Journal:  J Clin Med       Date:  2021-12-25       Impact factor: 4.241

Review 4.  Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions.

Authors:  Allan R Glanville; Christian Benden; Anne Bergeron; Guang-Shing Cheng; Jens Gottlieb; Erika D Lease; Michael Perch; Jamie L Todd; Kirsten M Williams; Geert M Verleden
Journal:  ERJ Open Res       Date:  2022-07-25

5.  The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease.

Authors:  Yifan Pang; Ananth V Charya; Michael B Keller; Arlene Sirajuddin; Yi-Ping Fu; Noa G Holtzman; Steven Z Pavletic; Sean Agbor-Enoh
Journal:  Blood Adv       Date:  2022-07-26

6.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.

Authors:  Daniel Wolff; Vedran Radojcic; Robert Lafyatis; Resat Cinar; Rachel K Rosenstein; Edward W Cowen; Guang-Shing Cheng; Ajay Sheshadri; Anne Bergeron; Kirsten M Williams; Jamie L Todd; Takanori Teshima; Geoffrey D E Cuvelier; Ernst Holler; Shannon R McCurdy; Robert R Jenq; Alan M Hanash; David Jacobsohn; Bianca D Santomasso; Sandeep Jain; Yoko Ogawa; Philipp Steven; Zhonghui Katie Luo; Tina Dietrich-Ntoukas; Daniel Saban; Ervina Bilic; Olaf Penack; Linda M Griffith; Meredith Cowden; Paul J Martin; Hildegard T Greinix; Stefanie Sarantopoulos; Gerard Socie; Bruce R Blazar; Joseph Pidala; Carrie L Kitko; Daniel R Couriel; Corey Cutler; Kirk R Schultz; Steven Z Pavletic; Stephanie J Lee; Sophie Paczesny
Journal:  Transplant Cell Ther       Date:  2021-06-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.